At the Cancer Research Horizons’ Innovation Summit 2023, key trends and challenges in cancer research were discussed, including the promising future of cancer vaccines influenced by COVID-19 advances. Infinitopes CEO & Co-founder, Jonathan Kwok, highlighted the company’s anticipation of launching cancer vaccine trials in 2024. The summit underscored the importance of genomic technologies, AI, and collaboration in accelerating cancer treatment development, emphasizing the need for a dynamic approach to overcome regulatory and financial hurdles in bringing innovations from lab to market. For more detailed insights, visit the full article here.
We use cookies to improve your experience on our website. You can accept all the cookies, reject them or select your cookie preferences by clicking the corresponding buttons. For more information, please see our cookie policy.
